bacteriocinscolicins

Colicins are a subset of bacteriocins produced by Escherichia coli and related enteric bacteria. Bacteriocins themselves are ribosomally synthesized antimicrobial proteins or peptides used by bacteria to inhibit closely related strains. Colicins are typically encoded on dedicated plasmids, often referred to as colicinogenic or Col plasmids, and are released into the environment under stress conditions.

Production of colicins is frequently tied to the bacterial stress response, including the SOS response triggered by DNA damage. The producer organism usually carries an immunity gene that protects it from its own toxin, and many Col plasmids also encode mechanisms to lyse the cell and release the toxin. Colicins generally consist of modular proteins with three functional domains: a receptor-binding domain that recognizes specific outer membrane receptors, a translocation domain that interacts with the TonB-ExbB-ExbD complex to cross the outer membrane, and a cytotoxic domain that carries out the toxic effect.

The cytotoxic activities of colicins vary and include pore formation in the inner membrane, DNases that degrade genomic DNA, and RNases that cleave rRNA or other RNA targets. The killing spectrum is typically narrow, targeting strains that share similar receptors and lacking the corresponding immunity protein.

Colicins have been used as tools in microbiology and are investigated as potential antimicrobial agents due to their specificity. Challenges for clinical use include narrow host range, potential for resistance, and delivery and stability concerns. Research continues to explore engineering of colicins for broader activity and therapeutic applications.